218 related articles for article (PubMed ID: 24912852)
1. Early targets of miR-34a in neuroblastoma.
De Antonellis P; Carotenuto M; Vandenbussche J; De Vita G; Ferrucci V; Medaglia C; Boffa I; Galiero A; Di Somma S; Magliulo D; Aiese N; Alonzi A; Spano D; Liguori L; Chiarolla C; Verrico A; Schulte JH; Mestdagh P; Vandesompele J; Gevaert K; Zollo M
Mol Cell Proteomics; 2014 Aug; 13(8):2114-31. PubMed ID: 24912852
[TBL] [Abstract][Full Text] [Related]
2. Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.
Chen QR; Yu LR; Tsang P; Wei JS; Song YK; Cheuk A; Chung JY; Hewitt SM; Veenstra TD; Khan J
J Proteome Res; 2011 Feb; 10(2):479-87. PubMed ID: 21182263
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.
Tivnan A; Tracey L; Buckley PG; Alcock LC; Davidoff AM; Stallings RL
BMC Cancer; 2011 Jan; 11():33. PubMed ID: 21266077
[TBL] [Abstract][Full Text] [Related]
4. miR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4α.
Li Z; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3072-3078. PubMed ID: 31343368
[No Abstract] [Full Text] [Related]
5. Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis.
Kaller M; Liffers ST; Oeljeklaus S; Kuhlmann K; Röh S; Hoffmann R; Warscheid B; Hermeking H
Mol Cell Proteomics; 2011 Aug; 10(8):M111.010462. PubMed ID: 21566225
[TBL] [Abstract][Full Text] [Related]
6. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
Cole KA; Attiyeh EF; Mosse YP; Laquaglia MJ; Diskin SJ; Brodeur GM; Maris JM
Mol Cancer Res; 2008 May; 6(5):735-42. PubMed ID: 18505919
[TBL] [Abstract][Full Text] [Related]
7. microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells.
Zhang H; Qi M; Li S; Qi T; Mei H; Huang K; Zheng L; Tong Q
Mol Cancer Ther; 2012 Jul; 11(7):1454-66. PubMed ID: 22564723
[TBL] [Abstract][Full Text] [Related]
8. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
10. A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells.
Patil KS; Basak I; Pal R; Ho HP; Alves G; Chang EJ; Larsen JP; Møller SG
PLoS One; 2015; 10(12):e0143969. PubMed ID: 26633009
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
Lu G; Sun Y; An S; Xin S; Ren X; Zhang D; Wu P; Liao W; Ding Y; Liang L
Exp Mol Pathol; 2015 Aug; 99(1):173-9. PubMed ID: 26103003
[TBL] [Abstract][Full Text] [Related]
12. miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells.
Yang B; Huang J; Liu H; Guo W; Li G
Tumour Biol; 2016 Feb; 37(2):1771-9. PubMed ID: 26318298
[TBL] [Abstract][Full Text] [Related]
13. Effects of MDM4 Gene Regulation by miR-34a on LOVO Cell Proliferation.
Li S; Pei Y; Zhang W; Sun L; Jiang M; Shang G; Niu S; Ma Z
Ann Clin Lab Sci; 2020 May; 50(3):342-347. PubMed ID: 32581023
[TBL] [Abstract][Full Text] [Related]
14. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
16. miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5.
Cheng X; Xu Q; Zhang Y; Shen M; Zhang S; Mao F; Li B; Yan X; Shi Z; Wang L; Sheng G; Zhang Q
Eur J Pharmacol; 2019 May; 850():53-63. PubMed ID: 30716314
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
18. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
[TBL] [Abstract][Full Text] [Related]
20. Micro(mi) RNA-34a targets protein phosphatase (PP)1γ to regulate DNA damage tolerance.
Takeda Y; Venkitaraman AR
Cell Cycle; 2015; 14(24):3830-41. PubMed ID: 26111201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
